Medicare Enrolled

Michelle Simmons, FNP-C

Nurse Practitioner - Primary Care · Dallas, TX
Practice pattern: Remote Monitoring — Significant remote device monitoring activity
3600 GASTON AVE STE 360, Dallas, TX 75246
2148203971
Registered in NPPES since 2015
NPI: 1306215660 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Simmons from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Simmons? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Simmons

Michelle Simmons is a nurse practitioner - primary care in Dallas, TX, with 10 years of NPI registration. Based on federal Medicare data, Simmons performed 1,029 Medicare services in 2023. These records do not provide a deduplicated patient total.

Between the years covered by Open Payments, Simmons received a total of $6,533 from 42 pharmaceutical and/or device companies across 346 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Simmons is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 10 years of NPI registration ▲ Top 16% volume in TX $6,533 industry payments

Medicare Practice Summary — 2023

Medicare Utilization ↗
1,029
Medicare services
Top 16% in TX for nurse practitioner - primary care
Not available
Unique patients (not deduplicated)
$64
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Definitive drug test using GC/MS or LC/MS
A definitive drug test that identifies specific drugs and distinguishes between structural isomers using advanced methods like GC/MS or LC/MS.
229 $110 $1,839
Drug screening test
A laboratory test that uses a chemistry analyzer to detect the presence of drugs in a sample.
228 $60 $500
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
174 $72 $375
Remote therapeutic monitoring, first 20 minutes
Physician management of remote therapeutic monitoring data for the first 20 minutes per calendar month.
119 $33 $300
Musculoskeletal remote monitoring device supply, 30 days
A device supply that records and transmits data for remote monitoring of the musculoskeletal system over a 30-day period.
114 $34 $271
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
98 $56 $275
Remote therapeutic monitoring, additional 20 minutes
This service covers the physician's time for managing remote therapeutic monitoring data beyond the initial monthly allotment. It applies for each additional 20-minute increment used within a calendar month.
35 $27 $296
Remote therapy monitoring setup and education
This service involves setting up equipment and providing patient education for the remote monitoring of therapy.
32 $13 $293
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.

Industry Payment Transparency

Open Payments through 2024 ↗
$6,533
Total received (2021-2024)
Avg $1,633/year across 4 years
Top 3% in TX for nurse practitioner - primary care
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
42
Companies
346
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,815
2023
$1,816
2022
$1,615
2021
$1,287

Payments by company (2024)

Collegium Pharmaceutical, Inc.
$325
ABBVIE INC.
$259
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$173
Abbott Laboratories
$153
SK Life Science, Inc.
$124
Forte Bio-Pharma LLC
$119
Amgen Inc.
$104
Kyowa Kirin, Inc.
$96
Averitas Pharma Inc.
$83
PFIZER INC.
$68
Medtronic, Inc.
$56
SPR Therapeutics, Inc
$46
IBSA Pharma Inc.
$43
Valinor Pharma, LLC
$36
SCILEX PHARMACEUTICALS INC.
$33
Saluda Medical Americas, Inc.
$28
Hikma Pharmaceuticals USA
$19
Avanos Medical
$18
Lilly USA, LLC
$18
VERTEX PHARMACEUTICALS INCORPORATED
$15
Top 3 companies account for 41.7% of 2024 payments
All-time payments by company (2021-2024) ›
Collegium Pharmaceutical, Inc.
$1,310
ABBVIE INC.
$846
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$760
Forte Bio-Pharma LLC
$474
BioDelivery Sciences International, Inc.
$214
GENZYME CORPORATION
$200
Scilex Pharmaceuticals Inc.
$197
Merck Sharp & Dohme LLC
$190
Lilly USA, LLC
$184
Abbott Laboratories
$180
FORTE BIO-PHARMA LLC
$168
SCILEX PHARMACEUTICALS INC.
$132
SK Life Science, Inc.
$124
Medtronic, Inc.
$111
Averitas Pharma Inc.
$109
Amgen Inc.
$104
PFIZER INC.
$104
Kyowa Kirin, Inc.
$96
RedHill Biopharma Inc.
$80
Valinor Pharma, LLC
$74
IBSA Pharma Inc.
$73
Vertos Medical, Inc.
$71
GRT US Holding, Inc.
$70
Biohaven Pharmaceutical Holding Company Ltd.
$67
SPR Therapeutics, Inc
$58
Hikma Pharmaceuticals USA
$55
Brainsway USA INC
$54
Almatica Pharma LLC
$49
USWM, LLC
$44
Pacira Therapeutics, Inc.
$42
Lundbeck LLC
$41
Allergan, Inc.
$35
Nevro Corp.
$33
Baudax Bio Inc.
$29
Saluda Medical Americas, Inc.
$28
Arbor Pharmaceuticals, Inc.
$21
Bioventus LLC
$19
Biohaven Pharmaceuticals, Inc.
$19
Avanos Medical
$18
Kowa Pharmaceuticals America, Inc.
$18
ARBOR PHARMACEUTICALS, INC.
$17
VERTEX PHARMACEUTICALS INCORPORATED
$15
Top 3 companies account for 44.6% of all-time payments
Associated products mentioned in payments ›
ANJESO · BELBUCA · BELSOMRA · BOTOX · Belbuca · Brainsway Deep TMS · Crysvita · EMGALITY · Evoke · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · GELSYN-3 · GRALISE · Horizant · INTELLIS ADAPTIVESTIM · KRYSTEXXA · KYPHON Balloon Kyphoplasty · Kloxxado · LICART · Licart · Lucemyra · MOVANTIK · Movantik · NALOCET · NAPRELAN · NURTEC ODT · Omnia · PROCLAIM · PROLATE · QULIPTA · QUTENZA · Qutenza · RELISTOR · REYVOW · SEGLENTIS · SPRINT PNS System · STANDARD RF DISPOSABLES · Tirosint · UBRELVY · VYEPTI · XCOPRI · XTAMPZA · ZTLido · Zilretta · mild Device Kit
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a nurse practitioner - primary care in Dallas?
Compare nurse practitioner - primary cares in the Dallas area by procedure volume, costs, and industry payment transparency.
Browse nurse practitioner - primary cares nearby

Geographic Context

Nurse practitioner - primary cares in nearby ZIP areas
154
County median income
$74,149
Nearest hospital to ZIP centroid (approximate)
BAYLOR UNIVERSITY MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Simmons is a remote monitoring specialist, with above-average Medicare volume (top 16% in TX).

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Simmons experienced with definitive drug test using gc/ms or lc/ms?
Based on Medicare claims data, Simmons performed 229 definitive drug test using gc/ms or lc/ms services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Simmons receive payments from pharmaceutical companies?
Yes. Simmons received a total of $6,533 from 42 companies across 346 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Simmons's costs compare to other nurse practitioner - primary cares in Dallas?
Simmons's average Medicare payment per service is $64. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Simmons) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →